GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Consort Medical PLC (GREY:CSRMY) » Definitions » Capex-to-Operating-Cash-Flow

Consort Medical (Consort Medical) Capex-to-Operating-Cash-Flow : 0.00 (As of Oct. 2019)


View and export this data going back to . Start your Free Trial

What is Consort Medical Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Consort Medical's Capital Expenditure for the six months ended in Oct. 2019 was $-9.37 Mil. Its Cash Flow from Operations for the six months ended in Oct. 2019 was $-0.13 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Consort Medical Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Consort Medical's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consort Medical Capex-to-Operating-Cash-Flow Chart

Consort Medical Annual Data
Trend Apr10 Apr11 Apr12 Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.71 0.59 0.45 0.69 0.68

Consort Medical Semi-Annual Data
Apr10 Oct10 Apr11 Oct11 Apr12 Oct12 Apr13 Oct13 Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.70 0.43 1.01 -

Competitive Comparison of Consort Medical's Capex-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, Consort Medical's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consort Medical's Capex-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Consort Medical's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Consort Medical's Capex-to-Operating-Cash-Flow falls into.



Consort Medical Capex-to-Operating-Cash-Flow Calculation

Consort Medical's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Apr. 2019 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-30.729) / 45.052
=0.68

Consort Medical's Capex-to-Operating-Cash-Flow for the quarter that ended in Oct. 2019 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-9.367) / -0.127
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Consort Medical  (GREY:CSRMY) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Consort Medical Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Consort Medical's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Consort Medical (Consort Medical) Business Description

Traded in Other Exchanges
N/A
Address
Breakspear Way, Suite B Breakspear Park, Hemel Hempstead, Hertfordshire, GBR, HP2 4TZ
Consort Medical PLC is part of the healthcare sector in the United Kingdom. It is one of the leading contract manufacturers in the field of drug delivery devices. Its core products include an inhaler, auto-injector, nasal and ocular technologies which it supplies to pharmaceutical companies. Along with devices, the company also specializes in drugs including active pharmaceutical ingredients and finished dose formulations.

Consort Medical (Consort Medical) Headlines

No Headlines